IL-2
[용어속성] Protein
Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy
Research
[키워드] CAR-T
CAR-T therapy
chimeric antigen receptor
clinical
Clinical characteristics
Complication
coronavirus disease
correlated
COVID-19
COVID-19 group
CRS
Cytokine release syndrome
Cytokines
demonstrated
diagnose
Disease progression
dramatic increase
evaluated
excessive immune response
GRADE
had more
hypertension
IFN-γ
IL-10
IL-2
IL-6
independent risk factor
induce
Inflammatory response
intensity
life-threatening
management
patients
Retrospective study
risk factor
severe COVID-19
significantly higher
significantly more
T-cell
therapy
TNF-α
Treatment
Viral load
[DOI] 10.1038/s41409-020-01060-5 [Article Type] Research
[DOI] 10.1038/s41409-020-01060-5 [Article Type] Research
A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] administration
age
antiviral therapy
approved
asked
assumption
blind
blinded
carried
Chemical
Chemotherapy
clinical
clinical trial
COVID
COVID-19
COVID-19 patient
COVID-19 positive patients
Cytokine analysis
cytokine profile
determine
dissemination
edentulous
Effectiveness
element
eligibility assessment
excluded
expected
explained
female
FIVE
Flow
gargles
Glasgow coma score
group
hospitalised
hydrogen
hypertonic
identify
IFN-γ
IL-10
IL-2
IL-4
IL-6
Immunological test
Inc.
inclusion criteria
Intervention
Intubated
Karachi
Laboratory
laboratory-confirmed
lesion
male
Mild
moderate disease
mucosal
nasal
Nasal lavage
number
objective
outcome
parallel group
participant
Patient
PCR test
positive controls
Primary outcome
product
protocol
provided
Purposive sampling
quantitative PCR
Radiotherapy
randomised
randomised controlled trial
real time
reducing
reduction in
Registered
reported
Research
Research question
salivary
Sample size
sealed
Standard
status
study group
Study protocol
subject
Symptoms
the patient
TNF-α
treated
Trial
unit
university
university hospital
Viral load
website
[DOI] 10.1186/s13063-020-04634-2 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04634-2 PMC 바로가기 [Article Type] Letter
Immuno-Inflammatory Characteristics in Low Severity COVID-19 Patients with Digestive Symptoms
Research Article
[키워드] abnormality
Activation
addition
analyzed
Characteristics
Clinical management
collected
correlation
Course
COVID-19
COVID-19 patient
COVID-19 patients
digestive
discharged
disease
displaying
global pandemic
IL-2
immuno-inflammatory
Inflammatory cytokine
Liver damage
manifestation
mild case
mild COVID-19 symptom
Mild symptom
no significant difference
outbreak
Patient
Pneumonia
prevention
respiratory symptom
respiratory symptoms
respiratory tract specimen
Result
rRT-PCR testing
SARS-CoV-2
severity
subsequent
Symptom
Symptoms
the disease
the patient
three group
three groups
TNF
[DOI] 10.1155/2020/1063254 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2020/1063254 PMC 바로가기 [Article Type] Research Article
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach
Bioinformatics
[키워드] acute respiratory syndrome
antigenic epitope
applied
approach
average
B-cell epitope
binding
bioinformatics
candidate vaccine
chimeric
Chimeric Peptide Vaccine
codon optimization
coronavirus
coronavirus disease
Coverage
COVID-19
Cytokines
demonstrated
docking
E protein
Ethnic groups
expression
IFN-γ
IgG1
IgG2
IgM
IL-2
Immune receptor
immune response
in silico Approach
International
mRNA
Muti-epitope
pandemic
peptide
predicted
proliferation
Proteins
public health emergency
SARS-CoV-2
secondary structure
T-cell
T-cell epitope
T-helper cell
TLR3
TLR4
Vaccine
vaccine candidate
Vaccine design
WHO
World Health Organization
[DOI] 10.7717/peerj.9572 PMC 바로가기 [Article Type] Bioinformatics
[DOI] 10.7717/peerj.9572 PMC 바로가기 [Article Type] Bioinformatics
Increased platelet distribution width and reduced IL-2 and IL-12 are associated with thrombocytopenia in Plasmodium vivax malaria
혈소판 분포 폭 증가와 IL-2 및 IL-12 감소는 플라스모디움 비박스 말라리아에서 혈소판 감소증과 관련이 있다.
Original Article
[키워드] IL-1 beta
IL-12p70
IL-2
Plasmodium vivax
Platelet
thrombocytopenia
[DOI] 10.1590/0074-02760200080 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1590/0074-02760200080 PMC 바로가기 [Article Type] Original Article
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
Molecular Biosciences
[키워드] acute respiratory syndrome
Analysis
antibody
Antibody Response
calculated
CD4+ T cell
characterized
chemiluminescence
CLIA
Clinical deterioration
Clinical outcome
complementary
coronavirus disease
Coronavirus-2
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 severity
Cytokine storm
disease
disease severity
IgG
IgG and IgM
IgG level
IgG levels
IgG response
IL-10
IL-2
IL-6
immune response
Inflammatory cytokine
initiated
Level
Neutrophil-to-lymphocyte ratio
NLR
non-severe patients
occurred
outcome
outcomes
Patient
phenotype
Phenotypes
Phenotyping
predict
Ratio
Respiratory disease
robust
SARS-CoV-2
sera
Severe patient
single center
Spread
stratified
Wuhan
[DOI] 10.3389/fmolb.2020.00157 PMC 바로가기 [Article Type] Molecular Biosciences
[DOI] 10.3389/fmolb.2020.00157 PMC 바로가기 [Article Type] Molecular Biosciences
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
Review article
[키워드] acute respiratory syndrome
characterized
Clinical outcome
Control
coronavirus
COVID-19
Critical
CRS
cytokine
Cytokine release syndrome
Cytokine storm
IL-10
IL-2
IL-7
indicated
Infection
intracellular signaling
involved
Jak
jak inhibitors
Jak-STAT
Janus kinase
pathophysiologic
pathway
Patient
recent
Release
SARS-CoV-2
severe coronavirus disease
severe COVID-19
targeting
therapeutic strategy
Treatment
[DOI] 10.1016/j.tips.2020.06.007 [Article Type] Review article
[DOI] 10.1016/j.tips.2020.06.007 [Article Type] Review article
Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients
Research Paper
[키워드] age
applied
cause
characteristic
clinician
collected
comparable
coronavirus
coronavirus disease
COVID-19
COVID-19 patients
COVID-2019
COX
cytokine level
cytokine profile
D-dimer
decrease
determine
diagnostic
Disseminated intravascular coagulation
evaluate
examined
flow cytometry
help
IL-10
IL-2
immunoassays
Inflammatory cytokine
Kaplan–Meier
laboratory result
Laboratory results
Liver function
lymphocyte
lymphopenia
mild cases
multiple organ
NLR
occurred
Patient
Peripheral blood sample
principal component analysis
Prognostic factor
Prognostic value
Proinflammatory cytokine
regression models
renal function
risk
Risk factors
SARS-CoV-2
second
severe COVID-19
severe COVID-19 patient
severity
significantly
subset
survived
sustained
T cell
the disease
threshold
Treatment
was used
were assessed
[DOI] 10.18632/aging.103255 PMC 바로가기 [Article Type] Research Paper
[DOI] 10.18632/aging.103255 PMC 바로가기 [Article Type] Research Paper
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)
중증 COVID-19 환자를 치료하기 위한 동종 인간 치수 줄기세포의 안전성 및 효능 평가: 무작위 대조 시험(I/II상)을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
Acidic
Adenovirus
Admission
AIDS
Alanine
alanine aminotransferase
albumin
alkaline phosphatase
Allogeneic
allogeneic human dental pulp stem cells
amyloid
Analysis
anion gap
Arm ratio
aspartate
Aspartate aminotransferase
average
B lymphocyte
basophils
Before menopause
Bilirubin
blind
blinded
Block randomization method
Blood
blood cell
Blood cells
blood pressure
Blood routine
C-reactive protein
calcium
carbon dioxide
Care
CAST
caused
Cell
cell suspension
change
chest X-ray
Child Pugh score
chlorine
cholesterol
cholinesterase
CLARITY
clinical
Clinical improvement
clinical trial
coded
Coefficient of variation
color
commenced
comparator
computer
Concentration
Consent
consent form
Continuous renal replacement therapy
control group
control groups
COVID-19
COVID-19; randomised controlled trial; protocol; human dental pulp stem cells; dental stem cell banking
COVID-2019
creatine
creatine kinase
creatinine
criteria
crystal
Cytokines
cytomegalovirus
cytomegalovirus CMV-IgG
cytomegalovirus CMV-IgM
Definition
dental pulp
dental pulp stem cells
description
detect
Diastolic blood pressure
direct bilirubin
discharge
disease
dissemination
distress
distribution
DPSCs
ECMO
Efficacy
element
enrolled
eosinophil
eosinophils
epithelial cells
estimated glomerular filtration rate
Estrogen
examined
excluded
exclusion criteria
experimental group
fat globules
Female patients
female subject
filtration rate
Final
flow cytometry
follow-up period
fungi
fungus
Globulin
glomerular filtration rate
Glucose
GRADE
Grade 1
grade 3
Grade 5
granulocyte
HBcAb
HBeAb
HBeAg
HBsAb
HBsAg
hDPSCs
Health Organization
heart rate
hematocrit
Hemodialysis
hemoglobin
hepatitis B
hepatitis C
HFNC
high density lipoprotein
hospitalised patient
Hospitalised patients
Hospitalization
Hospitalized
human DPSC
human DPSCs
hypersensitive C-reactive protein
hypoxia
Identifier
IgA
IgG
IgM
Il -10
IL-1
IL-1 β
IL-2
IL-4
IL-6
immune
Immunoglobulin
Immunological testing
improvement
IMV
inclusion criteria
Infectious disease
Influenza
Influenza virus
informed consent form
injection
Injections
intensive care
intensive care unit
Intravenous injection
Invasive mechanical ventilation
investigator
investigators
ITN-γ
ketone
ketone bodies
Kidney function
Kidney function tests
Killer cell
Laboratory
laboratory examinations
Lactate
lactate dehydrogenase
lactating women
leukocyte
leukocyte enzymes
lipoprotein
lipoprotein A
lipoprotein cholesterol
low density lipoprotein
lung lesion
lung lesions
lymphocyte
Lymphocytes
Macrophage
Magnesium
Medical care
Menopause
Monocytes
mononuclear cell
mononuclear cells
nasal
nasal catheter
natural killer
natural killer cell
neutrophil
Neutrophils
nitrite
NIV
Non-invasive
non-invasive mechanical ventilation
non-squamous epithelial cell
non-squamous epithelial cells
nucleic acid
nucleic acid test
number
objective
observation
occult
occult blood
Other
Other condition
outcome
oxygen
oxygen saturation
parallel group
parasites
partial pressure
participant
Patient
penetration
performed
Peripheral blood
Peritoneal dialysis
phase
phenotype
phosphatase
phosphorus
Placebo
placebo-controlled
Platelet
Platelet count
platelet distribution width
Platelets
Potassium
prealbumin
pregnancy test
pregnant
pressure
Primary outcome
Protein
protocol
random
randomisation
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
red blood cell
red blood cells
renal
renal insufficiency
renal replacement therapy
Renmin Hospital
replacement therapy
required
researcher
respiratory
respiratory distress
respiratory infection
respiratory rate
Safety
Saline
saline solution
Sample size
SARS-CoV-2
secondary
Secondary outcomes
serious COVID-19
serum
serum amyloid
severe liver condition
severe pneumonia
single-cell analyses
sodium
specific gravity
Standard deviation
status
stem cell
study period
Study protocol
sugar
syphilis
Systolic blood pressure
T lymphocyte
Th1 cytokine
Th1 cytokines
Th2 cytokine
Th2 cytokines
therapeutic effect
therapeutic effects
time
TNF-a
Total
total bilirubin
Total cholesterol
total protein
traits
Transferrin
treat
Treatment
treatment for COVID-19
triacylglycerol
Trial
triple blinded
TTCI
Tuberculosis
Twenty participant
Twenty participants
university
urea
uric acid
Urine
urobilinogen
Variation
Version
vital signs
Volume
website
White blood cells
with HIV
within 6 months
women
World Health Organization
Wuhan
γ-glutamyl transferase
[DOI] 10.1186/s13063-020-04380-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04380-5 PMC 바로가기 [Article Type] Letter